Voyageur Pharmaceuticals Ltd.
VYYRF
$0.12
$0.002.22%
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -86.83% | 19.46% | -86.11% | -264.44% | 6.20% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -33.33% | -33.33% | -33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 166.27% | -90.73% | -546.51% | 228.38% | 12.48% |
| Change in Net Operating Assets | 1,065.38% | 172.61% | 19.03% | -43.12% | -153.00% |
| Cash from Operations | 225.87% | 83.15% | -1,283.04% | -2,351.40% | -68.11% |
| Capital Expenditure | -93.84% | 35.14% | -156.42% | -108.71% | 47.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -93.84% | 35.14% | -156.42% | -108.71% | 47.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 29,039.29% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -235.87% | -- | 44.44% |
| Cash from Financing | -- | -- | -226.36% | 27,692.68% | 1,035.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 243.34% | -142.41% | -510.08% | 5,663.51% | -6.74% |